IP Library Assignment 055766/0572
Patent Assignment
Reel/Frame 055766/0572

Assignment of Assignor's Interest

Recorded: 2021-03-30 Pages: 34
Assignor
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, JAPAN
Covered Properties (53)
Treatment of Alpha-Galactosidase a Deficiency
Application: 16/276,039 →
Publication: US US20190255156A1
Compositions and Methods for Treating Gaucher Disease
Application: 14/169,628 →
Publication: US US20140242061A1
Methods for Purification of Arylsulfatase A
Application: 16/411,980 →
Publication: US US20200040317A1
Methods for Purification of Arylsulfatase A
Application: 14/759,645 →
Publication: US US20150353904A1
Methods and Compositions for Cns Delivery of Arylsulfatase A
Application: 15/999,472 →
Publication: US US20200179492A1
Anti-CCL2 and Anti-LOXL2 Combination Therapy for Treatment of Scleroderma
Application: 14/893,486 →
Publication: US US20160083482A1
Substrate Clearance Assays for Lysosomal Enzymes
Application: 15/119,324 →
Publication: US US20170219566A1
Anti-Flt-1 Antibodies for Treating Duchenne Muscular Dystrophy
Application: 16/991,762 →
Publication: US US20210206860A1
Conjugated C1 Esterase Inhibitor and Uses Thereof
Application: 15/479,139 →
Publication: US US20170360905A1
Recombinant Human C1 Esterase Inhibitor and Uses Thereof
Application: 15/777,547 →
Publication: US US20180334493A1
Conjugated C1 Esterase Inhibitor and Uses Thereof
Application: 15/955,212 →
Publication: US US20180333473A1
Anti-Flt-1 Antibodies in Treating Bronchopulmonary Dysplasia
Application: 15/565,009 →
Publication: US US20180100017A1
Recombinant Follistatin-Fc Fusion Proteins and Use in Treating Duchenne Muscular Dystrophy
Application: 16/082,070 →
Publication: US US20200247856A1
Compounds and Compositions for the Treatment of Ophthalmic Disorders
Application: 15/886,751 →
Publication: US US20180215788A1
Small Unit Dosage Plunger Rod Stops
Application: 15/804,439 →
Publication: US US20180126085A1
Modular Vial Adapter
Application: 15/840,004 →
Publication: US US20180161243A1
Smart Tourniquet
Application: 16/476,737 →
Publication: US US20190350593A1
Drug Monitoring Tool
Application: 15/876,827 →
Publication: US US20180218782A1
Drug Monitoring Tool
Application: 17/119,011 →
Publication: US US20210098103A1
Recombinant Follistatin-FC Fusion Proteins and Use in Treating Duchenne Muscular Dystrophy
Application: 15/977,635 →
Publication: US US20180362604A1
Physiological Sensing and Therapeutic Administration System and Method
Application: 16/480,167 →
Publication: US US20190365317A1
Antibody-Resin Coupling Apparatus and Methods
Application: 16/048,999 →
Publication: US US20190039042A1
Formulations Comprising Glucocerebrosidase and Isofagomine
Application: 16/759,201 →
Publication: US US20200316178A1
Methods and Compositions for Treating Chronic Lung Diseases
Application: 16/127,988 →
Publication: US US20190151411A1
Syringe Screening Device
Application: 16/268,738 →
Publication: US US20190250070A1
Affinity Purification of Glycoside-Cleaving Enzymes
Application: 16/978,417 →
Publication: US US20210040465A1
Anti-Flt-1 Antibodies in Treating Bronchopulmonary Dysplasia
Application: 17/255,254 →
Publication: US US20210261672A1
Female-Female Adapter
Application: 17/258,833 →
Publication: US US20210290486A1
Isofagomine Salts, Methods of Use and Formulations
Application: 62/838,445 →
Plasma Kallikrein Inhibitors and Uses Thereof
Application: 17/024,437 →
Publication: US US20210078999A1
Heteroaryl Plasma Kallikrein Inhibitors
Application: 17/024,189 →
Publication: US US20210079022A1
System and Methods for Electronic Portfolio Management
Application: 62/925,483 →
Needle Connectors and Modular Needle Connectors for Multi-Dose Drug Delivery Devices and Methods Thereof
Application: 63/073,158 →
Transkaryotic Implantation
Patent: 7,094,400 →
Application: 08/465,596 →
Treatment of Alpha-Galactosidase a Deficiency
Patent: 7,833,742 →
Application: 11/403,618 →
Publication: US US20060177433A1
Treatment of Alpha-Galactosidase a Deficiency
Application: 15/350,785 →
Publication: US US20170216411A1
Treatment of a-Galactosidase a Deficiency
Patent: 9,267,166 →
Application: 12/761,287 →
Publication: US US20110002908A1
Treatment of Alpha-Galactosidase a Deficiency
Patent: 9,523,113 →
Application: 14/995,540 →
Publication: US US20160184409A1
Crystal Structure of Human Alpha-N-Acetylglucosaminidase
Patent: 9,708,590 →
Application: 14/120,882 →
Publication: US US20150031112A1
Crystal structure of human alpha-N-acetylglucosaminidase
Patent: 8,775,146 →
Application: 13/136,092 →
Publication: US US20120021436A1
Enzymatic Activity Based-Detection
Patent: 9,383,359 →
Application: 14/299,358 →
Publication: US US20140302531A1
Competition-Based Detection Assays
Patent: 9,075,057 →
Application: 14/124,979 →
Publication: US US20140220595A1
Enzymatic Activity-Based Detection
Patent: 8,778,622 →
Application: 13/513,350 →
Publication: US US20120288874A1
Competition Based-Detection Assays
Patent: 9,562,904 →
Application: 14/729,498 →
Publication: US US20150338410A1
Assays for Detection of Glycosaminoglycans
Patent: 9,012,168 →
Application: 13/813,113 →
Publication: US US20130189718A1
Mitochondrial Targeting and Therapeutic Use Thereof
Patent: 9,932,377 →
Application: 14/993,500 →
Publication: US US20160237129A1
Mitochondrial Targeting and Therapeutic Use Thereof
Patent: 9,260,495 →
Application: 14/127,074 →
Publication: US US20140135275A1
Methods for Purification of Arylsulfatase A
Application: 14/128,468 →
Publication: US US20140205585A1
Compositions and Methods for Treating Type Iii Gaucher Disease
Patent: 9,623,090 →
Application: 14/381,680 →
Publication: US US20150071907A1
Follistatin in Treating Duchenne Muscular Dystrophy
Patent: 9,957,309 →
Application: 14/762,373 →
Publication: US US20160083440A1
Follistatin in Treating Duchenne Muscular Dystrophy
Application: 15/951,929 →
Publication: US US20180305421A1
Recombinant Placenta Growth Factor for Treating Duchenne Muscular Dystrophy
Application: 14/763,783 →
Publication: US US20150368309A1
Inhibitors of Plasma Kallikrein and Uses Thereof
Application: 16/299,996 →
Publication: US US20190284182A1
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 15, 2015
From: DANIEL, PETER F.; HEARTLEIN, MICHAEL W.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 035901/0249 →
Assignment of Assignor's Interest Oct 7, 2015
From: NICHOLS, DAVE; QUINONES-GARCIA, IGOR; CHEANG, BEE LIN; JANG, MEI HUEI
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 036744/0486 →
Assignment of Assignor's Interest Aug 5, 2016
From: MARTINI, PAOLO G.V.; NATARAJAN, MADHUSUDAN; HASLETT, PATRICK ANTHONY JOHN; SEYMOUR, ALBERT BARNES
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 039590/0694 →
Assignment of Assignor's Interest Mar 10, 2017
From: CHHAJLANI, VIJAY
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 041542/0144 →
Assignment of Assignor's Interest Sep 7, 2017
From: HOLMES, KEVIN; NORTON, ANGELA; PAN, CLARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 043515/0855 →
Assignment of Assignor's Interest Apr 19, 2018
From: SPOTTS, GERALD; PICHLER, ROMAN; NELSON, MICHAEL
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 045588/0922 →
Assignment of Assignor's Interest May 23, 2018
From: SAVINAINEN, ANNELI; SHAWER, MOHANNAD; DONG, JINQUAN
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 045879/0974 →
Assignment of Assignor's Interest Jul 18, 2018
From: BOWMAN, STEVE; FETZER, CHASE; BRAGA, RICHARD; SHIAKOLAS, EVI
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 046378/0550 →
Assignment of Assignor's Interest Oct 3, 2018
From: ARIAGNO, SCOTT RICHARD; ROUSH, DANIEL EDWARD
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 047057/0645 →
Assignment of Assignor's Interest Feb 21, 2019
From: TRECO, DOUGLAS A.; LOVEDAY, KENNETH; BOROWSKI, MARIANNE
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 048390/0603 →
Assignment of Assignor's Interest Feb 22, 2019
From: NORTON, ANGELA W.; COPPOLA, GERMANO
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 048412/0144 →
Assignment of Assignor's Interest Feb 22, 2019
From: WASILEWSKI, MARGARET; WIJATYK, ANNA
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 048416/0312 →
Assignment of Assignor's Interest May 23, 2019
From: YANG, YING; WANG, YONG
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049271/0852 →
Assignment of Assignor's Interest May 23, 2019
From: HOLMES, KEVIN; NORTON, ANGELA; PAN, CLARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049272/0223 →
Assignment of Assignor's Interest Nov 7, 2019
From: ISKENDERIAN, ANDREA; NORTON, ANGELA W.; SHEN, CHUAN; PAN, CLARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 050940/0720 →
Assignment of Assignor's Interest Jan 17, 2020
From: BATEMAN, DANIELLE; TOH, SEOK-CHOON; GU, QING
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 051548/0374 →
Assignment of Assignor's Interest Dec 11, 2020
From: SPOTTS, GERALD; PICHLER, ROMAN; NELSON, MICHAEL
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 054616/0312 →
Assignment of Assignor's Interest Jan 27, 2021
From: DAI, QI-DONG
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 055046/0387 →
Assignment of Assignor's Interest Sep 29, 2021
From: KEEFE, DENNIS
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 057634/0112 →